Australia & NZ

Fed:MS could be prevented with vaccine being trialled


Printer Friendly Send Article Subscribe Bookmark and Share

21/11/2008 - The debilitation disease multiple sclerosis could be prevented with a vaccine being trialled in Europe.

The disease affects more than 18,000 Australians.

University of Queensland researchers confirmed on Wednesday a link between the Epstein-Barr virus which causes glandular fever and is carried by more than 90 per cent of the world's population and multiple sclerosis, Fairfax reports.

Researchers say the vaccine, developed to combat glandular fever, could save thousands of lives.

However, some doctors warn the vaccine has not been fully tested as a preventative for multiple sclerosis and does not take into account the influence of environmental and genetic factors.

People with a parent, child or sibling with multiple sclerosis are at greater risk of contracting the disease, previous studies have shown.

Source: AAP NewsWire

Related News
Privacy issues surrounding medicare crackdown: AMA
Antibiotic resistant superbug detected at RNS hospital
Fed:Humans outliving their eyeballs, Aust scientist says
Childbirth fears are driving growth in caesareans:expert
Organ donor rates climb offering hope for those waiting
WA: Fed govt is ignoring aged care crisis,say providers
Fed:Aust scientists make a dengue fever breakthrough
Find information and suppliers:
Diagnostics & Disease Care
General Medical Suppliers
Hospital Equipment & Supplies
Pharmaceuticals & Drugs
Research & Development

Send this article to a colleague


 
To:  
  
From:  
   
Message:
(Optional)
 
Confirm:  
Protected by FormShield